HUMAN GENE TRANSFER/THERAPY PROTOCOL 
9212-034 
Crystal, Ronald G., National Heart, Lung, and Blood Institute; A Phase I 
Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological 
Efficacy of a Single Administration of a Replication Deficient, 
Recombinant Adenovirus Carrying the cDNA of the Normal Human Cystic 
Fibrosis Transmembrane Conductance Regulator Gene in the Lung. 
Date of RAC Approval: 12-3-92 
Recombinant DNA Research, Volume 16 
[615] 
